SELL - but trim 50-60% (vs proposed 20-30%), smaller core position, stop at $77.50, reload only on specific technical confirmation

• Technical breakdown confirmed below lower Bollinger band at $82.22, opening measured move toward $77.80
• Current position SELL with 50-60% trim recommended, leaving 25-30% core exposure (down from 50% proposed)
• Stop at $77.50 is tight - only 5.8% below $82.34 price versus ATR of $1.44 (1.75% of price)
• Dividend coverage at 2.7x drops to ~2.3x under 100bps stress ($1.1B additional interest against $13.8B operating cash flow, $18B+ EBITDA) - still within investment grade tolerance
• Supports trimming rather than adding, but 20-30% trim potentially undersized given compounding technical, macro, and regulatory risk
• Reload trigger: daily close above $84.53 on expanding volume with RSI above 40 and MACD histogram printing less-negative bar
• Five concurrent risk factors: broken technical structure with death cross forming, hawkish macro regime (1% September cut probability, 10% December), binary Dominion regulatory overhang, questionable EPS quality from special items, and tight stop relative to gap risk
• Support levels at $80.75, $78.60, and $77.80 (December 2025 capitulation low at $77.83)
• Fundamentals (25% margins, $32B construction pipeline, inflation-protected rate base cash flows) provide floor but do not prevent multiple compression
• Conservative position sizing critical - stop-out must represent acceptable portfolio damage, not catastrophic loss
• Aggressive Analyst's 1-to-3 risk ratio (6% to stop vs 15-20% upside to 50 SMA) is acceptable but not compelling given gap risk to December lows
• NEE blended cost of debt approximately 4-5 percent, Baa1/A- investment grade ratings
• Conservative analysis means disciplined action, not inaction - acknowledging risks and trimming more than feels comfortable

→ vs aggressive: Overselling balance sheet risk to justify urgency - 2.3x coverage under 100bps stress is still within investment grade tolerance, not dividend-at-risk territory

→ vs aggressive: Wrong to frame conservative/neutral positions as cowardly or complacent - patience is not paralysis, and confirming a breakdown before committing capital is proper risk management

→ vs aggressive: Calling the 50% core retention asymmetric is incorrect - 1-to-3 risk ratio (6% to stop vs 15-20% upside) is acceptable but not compelling, especially with gap risk to December lows

→ vs aggressive: Ignoring what fundamentals mean for the floor - NEE is not a speculative biotech or overleveraged REIT where regime shift permanently impairs business model

→ vs neutral: Stop placement too high at $80.90 or $82.22 - should be lowered to $77.80-$78.60 zone to account for overshoot in confirmed breakdown scenarios

→ vs neutral: Vague reload criteria (technical base formation) invites buying into a falling knife - needs specific criteria (daily close above $84.53, RSI >40, MACD histogram less-negative)

SELL with 35-45% trim; retain 55-65% core; stop at $76.00-$76.50; reload triggers at $86.53 or binary resolution

• The SELL direction is directionally correct given convergence of bearish technicals, hawkish macro, and binary regulatory risk
• Recommends 35-45% trim, splitting the difference between trader (20-30%) and Conservative Analyst (50-60%)
• Pushes stop from $77.50 to $76.00-$76.50, below the December 2025 capitulation low at $77.83
• December low has been tested twice, giving it more validity as structural support than $77.50
• Reload trigger: daily close above 200 SMA at $86.53 on above-average volume, OR clear Dominion overhang resolution
• Criticizes Conservative Analyst's triple-confirmation reload criteria as too restrictive to capture recovery
• NEE has 25% net margins, $32B construction pipeline, 2.7x dividend coverage ratio, investment grade ratings
• Aggressive Analyst overstates dividend risk: $13B operating cash flow, coverage at 2.7x dropping to 2.3x under rate stress is still investment grade territory
• EPS quality concern is real but secondary: 53% YoY EPS growth overstates underlying earnings power by 10-15% due to special items including $257M gain on business sale in Q1
• Operational metrics remain strong: revenue up 12%, gross margins sustained at 62%, operating cash flow up 46%
• Capital redeployment should align with hawkish macro thesis: shorter-duration credit, value-oriented dividend payers, regulated utilities with less deal exposure, or cash/short-duration Treasuries

→ vs aggressive: Overstates dividend risk: $13B operating cash flow with 2.7x coverage dropping to 2.3x under rate stress is still investment grade territory; dividend has been growing at double-digit pace with no signs of strain

→ vs aggressive: Rhetorical framing ('cowardly', 'complacent') creates bias toward action for action's sake rather than calibrated position management

→ vs aggressive: Recommends 50% core retention while claiming bearish conviction; this is the 'worst combination' of bear conviction with moderate positioning

→ vs aggressive: Reload trigger of 'if a technical base forms' is too loose and will get back in too early

→ vs conservative: Recommends 50-60% trim with only 25-30% core, which is ironically more aggressive than the Aggressive Analyst's plan despite claiming to be the cautious one

→ vs conservative: $77.50 stop is too tight given ATR of $1.44 and gap risk from binary events; a 5% gap-down would blow through the stop and core takes 8-10% hit before stop honored

→ vs conservative: Triple-confirmation reload criteria (daily close above $84.53, expanding volume, RSI above 40, MACD histogram less negative) is so restrictive it fires after 5-7% recovery has already occurred

→ vs conservative: Framing 50% core as 'overcommitted to an unconfirmed thesis' is overly bearish; thesis is not unconfirmed at fundamental level; NEE is high-quality compounder through difficult macro, not binary outcome bet